Treating Deep-Seated Tumors with Radiodynamic Therapy: Progress and Perspectives

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2024 Sep 28

PMID 39339173

Authors

Shengcang Zhu

Siyue Lin

Rongcheng Han

Affiliations

Soon will be listed here.

Abstract

Radiodynamic therapy (RDT), as an emerging cancer treatment method, has attracted attention due to its remarkable therapeutic efficacy using low-dose, high-energy radiation (such as X-rays) and has shown significant potential in cancer treatment. The RDT system typically consists of scintillators and photosensitizers (PSs). Scintillators absorb X-rays and convert them to visible light, activating nearby PSs to generate cytotoxic reactive oxygen species (ROS). Challenges faced by the two-component strategy, including low loading capacity and inefficient energy transfer, hinder its final effectiveness. In addition, the tumor microenvironment (TME) with hypoxia and immunosuppression limits the efficacy of RDTs. Recent advances introduce one-component RDT systems based on nanomaterials with high-Z metal elements, which effectively inhibit deep-seated tumors. These novel RDT systems exhibit immune enhancement and immune memory, potentially eliminating both primary and metastatic tumors. This review comprehensively analyzes recent advances in the rational construction of RDTs, exploring their mechanisms and application in the treatment of deep-seated tumors. Aimed at providing a practical resource for oncology researchers and practitioners, the review offers new perspectives for potential future directions in RDT research.

References

Takahashi J, Murakami M, Mori T, Iwahashi H . Verification of radiodynamic therapy by medical linear accelerator using a mouse melanoma tumor model. Sci Rep. 2018; 8(1):2728. PMC: 5807383. DOI: 10.1038/s41598-018-21152-z. View

Ngwa W, Irabor O, Schoenfeld J, Hesser J, Demaria S, Formenti S . Using immunotherapy to boost the abscopal effect. Nat Rev Cancer. 2018; 18(5):313-322. PMC: 5912991. DOI: 10.1038/nrc.2018.6. View

Ni K, Lan G, Chan C, Quigley B, Lu K, Aung T . Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy. Nat Commun. 2018; 9(1):2351. PMC: 6003951. DOI: 10.1038/s41467-018-04703-w. View

Nakayama M, Sasaki R, Ogino C, Tanaka T, Morita K, Umetsu M . Titanium peroxide nanoparticles enhanced cytotoxic effects of X-ray irradiation against pancreatic cancer model through reactive oxygen species generation in vitro and in vivo. Radiat Oncol. 2016; 11(1):91. PMC: 4936232. DOI: 10.1186/s13014-016-0666-y. View

Li X, Kwon N, Guo T, Liu Z, Yoon J . Innovative Strategies for Hypoxic-Tumor Photodynamic Therapy. Angew Chem Int Ed Engl. 2018; 57(36):11522-11531. DOI: 10.1002/anie.201805138. View

Riegman M, Sagie L, Galed C, Levin T, Steinberg N, Dixon S . Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture. Nat Cell Biol. 2020; 22(9):1042-1048. PMC: 7644276. DOI: 10.1038/s41556-020-0565-1. View

Lan G, Ni K, Xu R, Lu K, Lin Z, Chan C . Nanoscale Metal-Organic Layers for Deeply Penetrating X-ray-Induced Photodynamic Therapy. Angew Chem Int Ed Engl. 2017; 56(40):12102-12106. PMC: 5666692. DOI: 10.1002/anie.201704828. View

Ni K, Lan G, Chan C, Duan X, Guo N, Veroneau S . Ultrathin metal-organic layer-mediated radiotherapy-radiodynamic therapy enhances immunotherapy of metastatic cancers. Matter. 2020; 1(5):1331-1353. PMC: 7442115. View

Ding H, Yu H, Dong Y, Tian R, Huang G, Boothman D . Photoactivation switch from type II to type I reactions by electron-rich micelles for improved photodynamic therapy of cancer cells under hypoxia. J Control Release. 2011; 156(3):276-80. PMC: 3230725. DOI: 10.1016/j.jconrel.2011.08.019. View

10.

Formenti S, Demaria S . Systemic effects of local radiotherapy. Lancet Oncol. 2009; 10(7):718-26. PMC: 2782943. DOI: 10.1016/S1470-2045(09)70082-8. View

11.

Hashiguchi S, Kusuzaki K, Murata H, Takeshita H, Hashiba M, Nishimura T . Acridine orange excited by low-dose radiation has a strong cytocidal effect on mouse osteosarcoma. Oncology. 2002; 62(1):85-93. DOI: 10.1159/000048251. View

12.

Kefayat A, Ghahremani F, Motaghi H, Amouheidari A . Ultra-small but ultra-effective: Folic acid-targeted gold nanoclusters for enhancement of intracranial glioma tumors' radiation therapy efficacy. Nanomedicine. 2018; 16:173-184. DOI: 10.1016/j.nano.2018.12.007. View

13.

Zhang C, Zhao K, Bu W, Ni D, Liu Y, Feng J . Marriage of scintillator and semiconductor for synchronous radiotherapy and deep photodynamic therapy with diminished oxygen dependence. Angew Chem Int Ed Engl. 2014; 54(6):1770-4. DOI: 10.1002/anie.201408472. View

14.

Song G, Cheng L, Chao Y, Yang K, Liu Z . Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy. Adv Mater. 2017; 29(32). DOI: 10.1002/adma.201700996. View

15.

Sun W, Luo L, Feng Y, Cai Y, Zhuang Y, Xie R . Aggregation-Induced Emission Gold Clustoluminogens for Enhanced Low-Dose X-ray-Induced Photodynamic Therapy. Angew Chem Int Ed Engl. 2019; 59(25):9914-9921. DOI: 10.1002/anie.201908712. View

16.

Yang B, Chen Y, Shi J . Reactive Oxygen Species (ROS)-Based Nanomedicine. Chem Rev. 2019; 119(8):4881-4985. DOI: 10.1021/acs.chemrev.8b00626. View

17.

Yu M, Dai M, Liu Q, Xiu R . Oxygen carriers and cancer chemo- and radiotherapy sensitization: bench to bedside and back. Cancer Treat Rev. 2007; 33(8):757-61. DOI: 10.1016/j.ctrv.2007.08.002. View

18.

Dickens L, Powley I, Hughes M, MacFarlane M . The 'complexities' of life and death: death receptor signalling platforms. Exp Cell Res. 2012; 318(11):1269-77. DOI: 10.1016/j.yexcr.2012.04.005. View

19.

Dolmans D, Fukumura D, Jain R . Photodynamic therapy for cancer. Nat Rev Cancer. 2003; 3(5):380-7. DOI: 10.1038/nrc1071. View

20.

Zhang X, Luo Z, Chen J, Shen X, Song S, Sun Y . Ultrasmall Au(10-12)(SG)(10-12) nanomolecules for high tumor specificity and cancer radiotherapy. Adv Mater. 2014; 26(26):4565-8. DOI: 10.1002/adma.201400866. View